» Articles » PMID: 11789848

The Coronary Artery Bypass Conduit: I. Intraoperative Endothelial Injury and Its Implication on Graft Patency

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2002 Jan 16
PMID 11789848
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Prevention of intraoperative injury to the vascular endothelium is of primary importance in maintaining viability and patency of the aorto-coronary saphenous vein graft. Surgical manipulation, ischemia, storage conditions, and distension before anastomosis can abnormally alter the antithrombogenic property of the endothelium leading to vasospasms, thrombogenesis, occlusive intimal hyperplasia, and stenosis. Endothelial injury can also form an initiation site for the formation of later-stage atheromas and graft failure. A multifactorial strategy aimed at prevention of endothelial injury and graft failure should include improved surgical techniques, optimal preservation conditions, avoidance of nonphysiologic distension pressures, and use of specific pharmacologic agents as the primary form of intervention. The successful application of this strategy, and the development of newer and more efficacious strategies that may impact on long-term graft patency, can now be aided by assessment of the structural and functional integrity of bypass conduits using multiphoton imaging techniques.

Citing Articles

Impact of distension pressure on saphenous vein endothelial injury in coronary artery bypass grafting.

Das P, Sayyed A, Bharath S, Shales S, Das M, Pattari S Indian J Thorac Cardiovasc Surg. 2024; 40(4):424-432.

PMID: 38919177 PMC: 11194250. DOI: 10.1007/s12055-024-01731-8.


Pro-inflammatory role of Wnt/β-catenin signaling in endothelial dysfunction.

Wadey K, Somos A, Leyden G, Blythe H, Chan J, Hutchinson L Front Cardiovasc Med. 2023; 9:1059124.

PMID: 36794234 PMC: 9923234. DOI: 10.3389/fcvm.2022.1059124.


Luminal endothelialization of small caliber silk tubular graft for vascular constructs engineering.

Rizzi S, Mantero S, Boschetti F, Pesce M Front Cardiovasc Med. 2022; 9:1013183.

PMID: 36465472 PMC: 9708712. DOI: 10.3389/fcvm.2022.1013183.


Reply: Valveless saphenous vein grafts for coronary artery bypass grafting: First, do no harm.

Shapira O JTCVS Open. 2022; 8:382.

PMID: 36004180 PMC: 9390455. DOI: 10.1016/j.xjon.2021.09.001.


Adventitial Collagen Cross-Linking by Glutaraldehyde Reinforcing Human Saphenous Vein - Implication for Coronary Artery Bypass Grafting.

Liu C, Chen D, Li Z, Xu H, Gu C Braz J Cardiovasc Surg. 2022; 37(4):439-446.

PMID: 35976203 PMC: 9423789. DOI: 10.21470/1678-9741-2020-0587.